Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05064046 · ClinicalTrials.gov registry record · NA

Educating Providers About Lung Screening

A NA study, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
77
Enrollment target

NCT05064046: Completed NA study, sponsored by Georgetown University.

NCT05064046 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05064046, a NA study, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target

Study Summary

We are conducting a randomized trial to compare the Health Disparities module to an existing provider module on lung cancer screening to evaluate the impact on primary care providers' knowledge, attitudes, and lung cancer screening referrals of African American and White patients.

Primary Outcome

Knowledge about lung cancer screening

Interventions

  • BEHAVIORAL LuCa + Health Disparity module

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2021-10-27
Est. Completion 2022-07-27
Phase NA
Georgetown University

227 total trials

What the finished NCT05064046 record still lists

NCT05064046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which LuCa + Health Disparity module is the first listed.

NCT05064046 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05064046 about?

NCT05064046 is a clinical study titled "Educating Providers About Lung Screening". We are conducting a randomized trial to compare the Health Disparities module to an existing provider module on lung cancer screening to evaluate the impact on primary care providers' knowledge, attitudes, and lung cancer screening referrals of African American and White patients.

What is the current status of trial NCT05064046?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2021-10-27. Estimated completion is 2022-07-27.

What interventions are being tested in trial NCT05064046?

The interventions under investigation include: LuCa + Health Disparity module (BEHAVIORAL).

Who is sponsoring clinical trial NCT05064046?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05064046's enrollment target sits among peer trials

77 1062nd of 2000 higher than 939 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05064046, the US trial registry maintained by the National Library of Medicine. NCT05064046 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.